From looking at it, the auditors may have made an error: they allowed one-of revenue to be classified as recurring. I actually kept my shares at the time on the basis that the revenue was recurring, and I think (from memory, it was ages ago now), the shares issued to the ISX team was on the basis that the revenue was recurring.
If that is what they're going after, then there's a good chance they're going to win. It became quite clear in the aftermath that revenue was, in fact, one-of.
@ZMan
- Forums
- ASX - By Stock
- SP1
- ASIC v ISX Hearing
ASIC v ISX Hearing, page-660
-
- There are more pages in this discussion • 2,944 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SP1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online